MSAC has backed allowing dermatologists to supervise ECP treatment for rare skin cancers and chronic graft-versus-host disease.
End of content
No more pages to load
MSAC has backed allowing dermatologists to supervise ECP treatment for rare skin cancers and chronic graft-versus-host disease.
End of content
No more pages to load